GLP-1 receptor agonists × pharmacokinetics & dosing

SynthesisJournal of diabetes2025

Impact of GLP-1 Receptor Agonists on Suicide Behavior: A Meta-Analysis Based on Randomized Controlled Trials.

Jingqi Chen et al.PubMed ↗Full text ↗Publisher ↗

  • GLP-1 RA exposureno clear effectNo clear effect on suicidal behavior.Nothing cleared the noise.

What the trial testedas reported · 2025

Range includes no effect

No clear effect on suicidal behavior

−16%−46% to +32%

GLP-1 RA exposure vs control group

Bigger than 4 in 10 on the map

As reported

RR 0.84, 95% CI 0.54–1.32 · the paper's word: incidence of suicidal behavior

Who was studied, and how

people with type 2 diabetes, in this paper

The trial randomly assignedassigned by chance

GLP-1 RA exposure
control group

No clear effect on suicidal behavior−16%

randomised

the abstract, start to end

group and the control group (RR = 0.84, 95% CI: 0.54-1.32, p = 0.46, I

← favours treatmentfavours comparator →
could be chance
Incidence of suicidal behaviorGLP-1 RA exposure vs control group
RR 0.840.54–1.32
GLP-1 receptor agonistsPharmacokinetics & dosing

GLP-1 receptor agonists × pharmacokinetics & dosinghelps?mixed

unlikelylikely
0.00not counted
← favours treatmentfavours comparator →
more certainless certain
1 / 6

6 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40887719